Amphastar Pharmaceuticals

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AMPH and other ETFs, options, and stocks.

About AMPH

Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments.

CEO

Yong Feng Zhang

CEOYong Feng Zhang

Employees

2,028

Employees2,028

Headquarters

Rancho Cucamonga, California

HeadquartersRancho Cucamonga, California

Founded

1996

Founded1996

Employees

2,028

Employees2,028

AMPH Key Statistics

Market cap

1.19B

Market cap1.19B

Price-Earnings ratio

11.87

Price-Earnings ratio11.87

Dividend yield

—

Dividend yield—

Average volume

350.32K

Average volume350.32K

High today

$26.39

High today$26.39

Low today

$25.75

Low today$25.75

Open price

$25.97

Open price$25.97

Volume

124.47K

Volume124.47K

52 Week high

$45.39

52 Week high$45.39

52 Week low

$20.39

52 Week low$20.39

Stock Snapshot

As of today, Amphastar Pharmaceuticals(AMPH) shares are valued at $25.92. The company's market cap stands at 1.19B, with a P/E ratio of 11.87.

On 2025-12-09, Amphastar Pharmaceuticals(AMPH) stock traded between a low of $25.75 and a high of $26.39. Shares are currently priced at $25.92, which is +0.7% above the low and -1.8% below the high.

The Amphastar Pharmaceuticals(AMPH)'s current trading volume is 124.47K, compared to an average daily volume of 350.32K.

During the past year, Amphastar Pharmaceuticals(AMPH) stock moved between $20.39 at its lowest and $45.39 at its peak.

Analyst ratings

57%

of 7 ratings

Buy

42.9%

Hold

57.1%

Sell

People also own

Based on the portfolios of people who own AMPH. This list is generated using Robinhood data, and it’s not a recommendation.